Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Investigation of Vinpocetine (Cavinton) for Treatment of Acute Cerebral Infarction, an Open, Multicenter, Randomized, Control Study

NCT01400035 is registered in ClinicalTrials.gov with Shanghai Rxmidas Pharmaceuticals Co. Ltd. as lead sponsor.

NCT NCT01400035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Investigation of Vinpocetine (Cavinton) for Treatment of Acute Cerebral Infarction, an Open, Multicenter, Randomized, Control Study
Lead sponsor
Shanghai Rxmidas Pharmaceuticals Co. Ltd.
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
May 31, 2013
Enrollment
610 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction